Material Agreements

Tempest Therapeutics, Inc. entered into Registration Rights Agreement with Institutional Investors and Factor Bioscience Inc. valued at Obligation to file resale registration statement within 15 calendar days and use best efforts to hav (effective 2026-03-20).

“On March 20, 2026, the Company also entered into a registration rights agreement with the Investors (the “ Registration Rights Agreement ”), pursuant to which the Company agreed to file registration statements under the Securities Act, with the Securities and Exchange Commission (the “ SEC ”), covering the resale of the Shares to be issued in the Private Placement and the shares of Common Stock underlying the Common Warrants and Pre-Funded Warrants no later than 15 calendar days following the date of the Purchase Agreement, and to use reasonable best efforts to have the registration statement declared effective by 45 calendar days following the date of the Purchase Agreement, and in any event no later than 75 calendar days following the date of the Purchase Agreement in the event of a “full review” by the SEC (the “ Effectiveness Date ”).”

Tempest Therapeutics, Inc. entered into Securities Purchase Agreement with Institutional Investors and Factor Bioscience Inc. valued at Aggregate gross proceeds of approximately $2.0 million from the sale of 462,964 shares and pre-funde (effective 2026-03-20).

“On March 20, 2026, Tempest Therapeutics, Inc. (the “ Company ”) entered into a securities purchase agreement (the “ Purchase Agreement ”) with (a) two institutional investors (the “ Institutional Investors ”) and (b) Factor Bioscience Inc. (the “ Strategic Investor ” and, together with the Institutional Investors, each, an “ Investor ” and, together, the “ Investors ”), pursuant to which the Company agreed to issue and sell in a private placement (the “ Private Placement ”) an aggregate of 462,964 shares (the “ Shares ”) of the Company’s common stock, $0.001 par value per share (the “ Common Stock ”), and, in lieu of Common Stock, pre-funded warrants to purchase up to 462,963 shares of Common Stock (the “ Pre-Funded Warrants ”), in each case accompanied by (i) Series A warrants to purchase up to 925,927 shares of Common Stock (the “ Series A Warrants ”) and (ii) Series B warrants to purchase up to 925,927 shares of Common Stock (the “ Series B Warrants ” and, together with the Series A”

RenovoRx, Inc. entered into Securities Purchase Agreement with 15 accredited investors or qualified institutional buyers valued at aggregate gross proceeds of approximately $10 million (effective 2026-03-17).

“On March 17, 2026, RenovoRx, Inc., a Delaware corporation (the “Company”), entered into a securities purchase agreement (the “Securities Purchase Agreement”) in connection with a private placement offering by the Company (the “Offering”) to 15 accredited investors or qualified institutional buyers (the “Investors”), five of whom are directors, officers or employees of the Company (the “Insiders”) and the remaining are non-affiliated institutional investors (the “Institutional Investors”).”

PERRIGO Co plc entered into Amended and Restated Credit Agreement with JPMorgan Chase Bank, N.A. and J. P. Morgan SE, as administrative agent, JPMorgan Chase Bank, N.A., as collateral agent and the other lenders party thereto valued at $1.0 billion revolving credit facility (effective 2026-03-20).

“On March 20, 2026 (the “Effective Date”), the Company entered into an Amended and Restated Credit Agreement (the “Amended and Restated Credit Agreement”) with Perrigo Investments, the other subsidiaries of the Company named therein, JPMorgan Chase Bank, N.A. and J. P. Morgan SE, as administrative agent, JPMorgan Chase Bank, N.A., as collateral agent and the other lenders party thereto.”

California Resources Corp entered into First Supplemental Indenture with Wilmington Trust, National Association (effective 2026-01-16).

“The terms of the Notes are governed by the Indenture, dated as of October 8, 2025 (the “Original Indenture”, as amended and supplemented by the First Supplemental Indenture, dated as of January 16, 2026 (the “First Supplemental Indenture” and together with the Original Indenture, the “Indenture”)), by and among the Company, the guarantors party thereto (the “Guarantors”) and Wilmington Trust, National Association, as trustee (the “Trustee”).”

California Resources Corp entered into Indenture with Wilmington Trust, National Association valued at $350 million aggregate principal amount (effective 2026-03-23).

“On March 23, 2026, California Resources Corporation (the “Company”) completed its previously announced upsized private offering of an additional $350 million aggregate principal amount of its 7.000% senior unsecured notes due 2034”

Roivant Sciences Ltd. entered into Settlement Agreement with Moderna, Inc. and ModernaTx, Inc. (together, "Moderna") (effective 2026-03-03).

“on March 3, 2026, Genevant, Arbutus and, solely for certain purposes, GSL, entered into a Settlement Agreement with Moderna to resolve all patent infringement litigation between Genevant/Arbutus and Moderna pending in the U.S. and internationally relating to Moderna's use of Genevant/Arbutus’ lipid nanoparticle delivery technology in its vaccines.”

Ondas Inc. entered into Agreement and Plan of Merger with World View Enterprises Inc. valued at $150,000,000 (effective 2026-03-23).

“On March 23, 2026, Ondas Inc. (the “Company”) entered into an Agreement and Plan of Merger (the “Agreement”), by and among the Company, Wassaic Merger Sub Inc., a Delaware corporation and a wholly owned subsidiary of the Company (“Merger Sub”), World View Enterprises Inc., a Delaware corporation (the “World View”), and Fortis Advisors LLC, a Delaware limited liability company, in its capacity as the Representative (as defined in the Agreement).”

STARTENGINE CROWDFUNDING, INC. entered into Agreement and Plan of Reorganization with Vinovest, Inc., Project Vineyard Acquisition Inc., Andrew Zhang, and Participating Stockholders of Vinovest (effective 2026-03-17).

“On March 17, 2026, StartEngine Crowdfunding, Inc. (the “StartEngine” or “Company”) entered into an Agreement and Plan of Reorganization (the “Merger Agreement”) with Vinovest, Inc., a privately-held company located in West Hollywood, California (“Vinovest”), Project Vineyard Acquisition Inc., a wholly-owned subsidiary of StartEngine (“Merger Sub”), Andrew Zhang, solely in his capacity as the representative, agent and attorney-in-fact of the Participating Stockholders (the “Stockholders’ Representative”), and the Participating Stockholders of Vinovest.”

Crypto Co entered into Mutual Transfer and Release Agreement with Starchive.io, Inc., Peter Agelasto IV, Richard G. Averitt, Digital Relab LLC, and Richard Averitt as Sellers' representative (effective 2026-03-19).

“On March 19, 2026, The Crypto Company, a Nevada corporation (the “Company”), entered into a Mutual Transfer and Release Agreement (the “Agreement”) with Starchive.io, Inc., a Delaware corporation (the “Starchive”), Peter Agelasto IV, Richard G. Averitt, and Digital Relab LLC (collectively, the “Sellers”), and Richard Averitt, solely in his capacity as the Sellers’ representative.”

Azitra, Inc. entered into Securities Purchase Agreement with the purchasers named therein valued at gross proceeds of up to approximately $31.4 million (effective 2026-03-18).

“On March 18, 2026, Azitra, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with the purchasers named therein (the “Purchasers”), pursuant to which the Company agreed to issue and sell an aggregate of (i) 10,485 shares of its Series A convertible non-redeemable preferred stock, par value $0.0001 per share (the “Series A Preferred Stock”), (ii) Series B warrants (the “Series B Warrants”) to purchase up to 85,233,126 shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”) (or, in certain circumstances, pre-funded warrants to purchase shares of Common Stock (the “Pre-Funded Warrants”)), (iii) Series C warrants to purchase up to 85,233,126 shares of Common Stock (or, in certain circumstances, Pre-Funded Warrants) (the “Series C Warrants” and, together with the Series B Warrants, the “Warrants”) to the Purchasers in a private placement (the “PIPE Financing”).”

Serina Therapeutics, Inc. amended a notes offering with holders of its outstanding Senior Unsecured Convertible Promissory Note.

“As a condition to the initial closing, the Company and the holders of its outstanding Senior Unsecured Convertible Promissory Note, dated September 9, 2025, entered into an amendment of such note, effective upon the initial closing, removing any further obligations to borrow or loan funds under the Note.”

Serina Therapeutics, Inc. entered into Securities Purchase Agreement with Greg Bailey, as lead investor, and certain other investors valued at $15.0 million (effective 2026-03-17).

“On March 17, 2026, Serina Therapeutics, Inc. (the “ Company ”) entered into a Securities Purchase Agreement (the “ Purchase Agreement ”) with Greg Bailey, as lead investor, and certain other investors (collectively, the “ Investors ”), pursuant to which the Company agreed to issue and sell, in a private placement (the “ Private Placement ”), shares of its common stock, par value $0.0001 per share (the “ Common Stock ”), pre-funded warrants to purchase shares of Common Stock (the “ Pre-Funded Warrants ”) redeemable warrants to purchase shares of Common Stock (the “ Redeemable Warrants ” and, together with the Common Stock and the Pre-Funded Warrants, the “ Securities ”).”

Fathom Holdings Inc. entered into Subsidiary Guarantee with Bed Bath & Beyond, Inc. (effective 2026-03-18).

“In connection with the Bridge Note, on March 18, 2026, the Company, the Material Subsidiaries (as defined in the Bridge Note), and the Investor entered into (i) a security agreement (the “Security Agreement”) and (ii) a subsidiary guarantee (the “Subsidiary Guarantee”).”

Fathom Holdings Inc. entered into Security Agreement with Bed Bath & Beyond, Inc. (effective 2026-03-18).

“In connection with the Bridge Note, on March 18, 2026, the Company, the Material Subsidiaries (as defined in the Bridge Note), and the Investor entered into (i) a security agreement (the “Security Agreement”) and (ii) a subsidiary guarantee (the “Subsidiary Guarantee”).”

Fathom Holdings Inc. entered into Bridge Note with Bed Bath & Beyond, Inc. valued at $2,000,000 (effective 2026-03-18).

“On March 18, 2026, Fathom Holdings Inc. (the “Company”) entered into a subordinated secured promissory note in the original principal amount of $2,000,000 (the “Bridge Note”) with Bed Bath & Beyond, Inc. (the “Investor”).”

Guardian Pharmacy Services, Inc. entered into Stock Purchase Agreement with certain holders valued at up to an aggregate of 1,833,344 shares of Class A common stock (effective 2026-03-18).

“On March 18, 2026, Guardian Pharmacy Services, Inc. (the “Company”) entered into stock purchase agreements (each, a “Stock Purchase Agreement” and collectively, the “Stock Purchase Agreements”) with certain holders (the “Holders”) of shares of the Company’s Class A common stock that were issued upon conversion of shares of the Company’s Class B common stock originally issued in connection with the Company’s corporate reorganization in September 2024.”

MSP Recovery, Inc. entered into Advance Letter with VRM MSP Recovery Partners, LLC valued at $0.1 million (effective 2026-03-20).

“On March 20, 2026, the Company entered into a letter agreement (the “Advance Letter”) with VRM MSP Recovery Partners, LLC (“VRM”), pursuant to which VRM agreed to make available a one-time advance of recovery proceeds of $0.1 million to be used primarily to support the Company’s accounts payables.”

MSP Recovery, Inc. entered into Hazel Letter Agreement with Hazel Partners Holdings LLC valued at $0.1 million (effective 2026-03-23).

“On March 23, 2026, MSP Recovery, Inc. (the “Company”), through its subsidiaries, entered into a letter agreement with Hazel Partners Holdings LLC (“Hazel”), in its capacity as administrative agent and lender under the Company’s existing working capital credit facility (the “Hazel Letter Agreement”) to provide $0.1 million to be used primarily for operating expenses.”

Concentrix Corp amended Sixth Amendment to the Receivables Financing Agreement with PNC Bank, National Association valued at up to $750 million (effective 2026-03-20).

“On March 20, 2026, Concentrix Corporation (the “Company”), as servicer, entered into an amendment (the “Amendment”) to its accounts receivable securitization facility (as amended, the “Securitization Facility”) by and among Concentrix Receivables, Inc., a subsidiary of the Company, as borrower, PNC Bank, National Association, as administrative agent, and the group agents and the lenders party thereto.”

Empery Digital Inc. entered into Securities Purchase Agreement with certain institutional investors named on the signature page thereto valued at approximately $25 million (effective 2026-03-23).

“On March 23, 2026, Empery Digital Inc. (the “Company”) entered into a securities purchase agreement (the “Securities Purchase Agreement”) with certain institutional investors named on the signature page thereto”

Core Scientific, Inc./tx amended Amendment No. 1 to Delayed-Draw Bridge Credit Agreement with Morgan Stanley Senior Funding, Inc. and JPMorgan Chase Bank, N.A. valued at $500.0 million (effective 2026-03-18).

“On March 18, 2026 (the “Closing Date”), Core Scientific, Inc. (the “Company”) entered into Amendment No. 1 to Delayed-Draw Bridge Credit Agreement (the “Incremental Amendment”), by and among the Company, as borrower, Morgan Stanley Senior Funding, Inc., as administrative agent and collateral agent (in such capacity, the “Agent”), and JPMorgan Chase Bank, N.A. (“JPM”), as amendment no. 1 term lender, which amends the Company’s existing credit agreement (the “Initial Credit Agreement”) with the lenders party thereto from time to time and the Agent to increase the term loan commitments thereunder by $500.0 million, to $1.0 billion total, pursuant to the accordion feature of the Initial Credit Agreement.”

ZRCN Inc. entered into Loan Agreement with Altriarch Holdings SPV, LLC valued at $12.5 million senior secured revolving credit facility (effective 2026-03-17).

“On March 17, 2026 (the “Effective Date”), ZRCN Inc., a Delaware corporation (the “Company”), and its wholly owned subsidiary, Zircon Corporation, a California corporation (“Zircon” and collectively with the Company, the “Debtor”), entered into a Loan and Security Agreement (the “Loan Agreement”) with Altriarch Holdings SPV, LLC, as lender (“Lender”).”

Unusual Machines, Inc. entered into Placement Agency Agreement with Dominari Securities LLC and JonesTrading Institutional Services LLC valued at $150 million (effective 2026-03-19).

“On March 19, 2026, Unusual Machines, Inc. (the “Company”) entered into a Placement Agency Agreement (the “Agreement”) with Dominari Securities LLC and JonesTrading Institutional Services LLC (combined together hereinafter referred to as the “Placement Agents”), relating to the confidentially marketed public offering (the “Offering”) of 8,823,529 shares of the Company’s common stock, at a price to the public of $17.00 per share.”

NEONC TECHNOLOGIES HOLDINGS, INC. entered into third Securities Purchase Agreement with one investor valued at $1,000,000 (effective 2026-03-20).

“arch 20, 2026, the Company entered into a third Securities Purchase Agreement to issue and sell up to the remaining 545,583 Shares at”

NEONC TECHNOLOGIES HOLDINGS, INC. entered into second Securities Purchase Agreement with four investors valued at $1,450,004 (effective 2026-02-24).

“on February 24, 2026, the Company entered into a second Securities Purchase Agreement to issue and sell up to the remaining 746,973 Shares”

NEONC TECHNOLOGIES HOLDINGS, INC. entered into Securities Purchase Agreement with single institutional investor valued at $10 million (effective 2026-01-29).

“on January 29, 2026, NeOnc Technologies Holdings, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Agreement”) to issue and sell up to 2,222,222 shares”

Aureus Greenway Holdings Inc entered into Convertible Note with Autonomous Power Corporation valued at $20,000,000 (effective 2026-03-20).

“the Company agreed to purchase from APC a senior unsecured convertible promissory note in the original principal amount of $20,000,000 (the “Convertible Note”)”

Aureus Greenway Holdings Inc entered into Securities Purchase Agreement with Autonomous Power Corporation (effective 2026-03-20).

“On March 20, 2026, Aureus Greenway Holdings Inc. (the “Company”) entered into a securities purchase agreement (the “Securities Purchase Agreement”) with Autonomous Power Corporation”

INFINITY NATURAL RESOURCES, INC. entered into Indenture with U.S. Bank Trust Company, National Association valued at $550.0 million (effective 2026-03-20).

“On March 20, 2026 (the “Closing Date”), Infinity Natural Resources, LLC (the “Issuer”) closed the previously announced private offering of $550.0 million aggregate principal amount of 7.625% senior notes due 2031 (the “Notes”). The Notes were issued under the Indenture, dated as of March 20, 2026 (the “Indenture”), by and among the Issuer, the guarantors party thereto (the “Guarantors”) and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”).”

Resolute Holdings Management, Inc. amended Credit Agreement Amendment with JPMorgan Chase Bank, N.A., as administrative agent, and the lenders party thereto valued at $10 million increase (effective 2026-03-18).

“On March 18, 2026, Resolute Holdings Management, Inc., a Nevada corporation (“Resolute Holdings” or the “Company”), entered into an Incremental Amendment (the “Credit Agreement Amendment”), to the Company’s existing Credit Agreement, dated as of February 20, 2026 (the “Existing Credit Agreement,” as amended by the Credit Agreement Amendment, the “Amended Credit Agreement), by and among the Company, as borrower, the lenders party thereto, JPMorgan Chase Bank, N.A., as administrative agent (the “Administrative Agent”) and the other parties named therein.”

Liberty Live Holdings, Inc. entered into Indenture with U.S. Bank Trust Company, National Association valued at approximately $1,116 million aggregate principal amount (effective 2026-03-20).

“f the New Debentures, on March 20, 2026, the Company entered into an indenture (the “Indenture”) with U.S. Bank Trust Company, National Association, as trustee.”

Janus Living, Inc. entered into Underwriting Agreement with BofA Securities, Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters (effective 2026-03-19).

“the Company entered into the Underwriting Agreement, dated March 19, 2026, by and among the Company, Janus Living OP, LLC (the “Operating Company”), Healthpeak Investment Management, LLC, as external manager to the Company (the “Manager”), and BofA Securities, Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters named therein (the “Underwriting Agreement”).”

Coeur Mining, Inc. entered into Credit Agreement with National Bank of Canada, as administrative agent valued at $1,000,000,000 senior secured revolving credit facility (effective 2026-03-20).

“On March 20, 2026, Coeur entered into a Credit Agreement (the “ Credit Agreement”) by and among Coeur, as borrower, certain subsidiaries of Coeur, as guarantors, the lenders party thereto and National Bank of Canada, as administrative agent.”

NORTECH SYSTEMS INC entered into Associated Facility with Associated Bank, National Association valued at $15,000,000 (effective 2026-03-20).

“On March 20, 2026, we entered into a new Credit and Security Agreement with Associated Bank, National Association, which provides for a revolving credit facility of up to $15,000,000”

HARMONIC INC. entered into Asset Purchase Agreement with Leone Media Inc. (d/b/a MediaKind) valued at $145 million (effective 2026-03-20).

“(the “Company”) entered into a Put Option Agreement (the “Put Option Agreement”) between the Company and Leone Media Inc. (d/b/a MediaKind) (the “Buyer”). Pursuant to the Put Option Agreement, the Company had the right (the “Put Option”) to require the Buyer to purchase the Company’s Video Business (the “Business”) for a purchase price of $145 million in cash, which Put Option may be exercised only following completion of the required consultation process with the relevant employee works council in France, with respect to such asset sale by the Company (the “Acquisition”).”

SONOCO PRODUCTS CO entered into Term Credit Agreement with lenders party thereto and Wells Fargo Bank, National Association, as Administrative Agent valued at $300 million (effective 2026-03-23).

“On March 23, 2026, Sonoco Products Company (the “Company”) entered into a credit agreement with the lenders party thereto and Wells Fargo Bank, National Association, as Administrative Agent (the “Term Credit Agreement”).”

DOLLAR TREE, INC. terminated 364-day revolving credit agreement with JPMorgan Chase Bank, N.A., as administrative agent valued at all commitments have been terminated and all obligations have been fulfilled (effective 2026-03-20).

“upon its expiration on March 20, 2026, all commitments have been terminated and all obligations have been fulfilled under the Company’s existing 364-day revolving credit agreement, dated as of March 21, 2025, as amended, restated, supplemented or otherwise modified from time to time, by and among the Company, as borrower, the banks and financial institutions from time to time party thereto, the issuers of letters of credit party thereto and JPMorgan Chase Bank, N.A., as administrative agent.”

DOLLAR TREE, INC. entered into Term Loan Credit Agreement with Bank of America, N.A., as agent, and the banks, financial institutions and other institutional lenders from time to time party thereto valued at $500 million term loan credit facility (effective 2026-03-19).

“On March 19, 2026, Dollar Tree, Inc., a Virginia corporation (the “Company”), entered into a credit agreement (the “Term Loan Credit Agreement”), with Bank of America, N.A., as agent, and the banks, financial institutions and other institutional lenders from time to time party thereto, providing for a $500 million term loan credit facility (the “Term Loan Facility”).”

TG THERAPEUTICS, INC. amended First Amendment with Blue Owl Capital Corporation, as administrative agent, and the lenders party thereto valued at $750 million term loan facility (effective 2026-03-18).

“On March 18, 2026 (the “Closing Date”), the Company (the “Borrower”) entered into the first amendment agreement, dated as of the Closing Date (the “First Amendment”), by and among the Borrower, certain subsidiaries of the Borrower, as guarantors, the lenders party thereto and Blue Owl Capital Corporation, as administrative agent (the “Administrative Agent”), which amends the financing agreement, dated as of August 2, 2024”

COLUMBIA SPORTSWEAR CO terminated Credit Agreement dated July 12, 2022 with JPMorgan Chase Bank, N.A. valued at Termination of prior credit facility with no outstanding loans (effective 2026-03-19).

“On March 19, 2026, in connection with the Company’s entry into the Credit Agreement described in Item 1.01 above, the Company terminated the Credit Agreement dated July 12, 2022 with JPMorgan Chase Bank, N.A., as the administrative agent for the lenders and as a lender, and the lenders party thereto (the “Prior Credit Agreement”). The Company had no outstanding loans under the Prior Credit Agreement and all other obligations under the Prior Credit Agreement have been paid, with the exception of letters of credit issued under the Prior Credit Agreement which are now issued under the Credit Agreement.”

COLUMBIA SPORTSWEAR CO entered into Credit Agreement with JPMorgan Chase Bank, N.A. valued at $500 million unsecured revolving credit facility (effective 2026-03-19).

“On March 19, 2026, Columbia Sportswear Company (the “Company”) entered into a Credit Agreement (the “Credit Agreement”) with JPMorgan Chase Bank, N.A., as the administrative agent for the lenders and as a lender (the “Administrative Agent”), and the other lenders party thereto. The Credit Agreement provides for up to $500 million of borrowings in U.S. Dollars pursuant to an unsecured revolving credit facility (the “Credit Facility”), which is available for working capital and general corporate purposes, including a sublimit for the issuance of letters of credit.”

BEASLEY BROADCAST GROUP INC entered into Transaction Support Agreement with holders of Existing Notes (the "Supporting Holders") (effective 2026-03-20).

“On March 20, 2026, Beasley Broadcast Group, Inc. (the “ Company ”), on behalf of itself and its direct and indirect subsidiaries, including Beasley Mezzanine Holdings, LLC (the “ Issuer ”), entered into a Transaction Support Agreement (the “ TSA ”) with holders of Existing Notes (as defined below) (the “ Supporting Holders ”) that, as of such date, beneficially owned approximately (a) 98.7% of the aggregate outstanding principal amount of the 11.000% Senior Secured First Lien Notes due 2028 (the “ Existing First Lien Notes ”) and (b) 76.5% of the aggregate outstanding principal amount of the 9.200% Senior Secured Second Lien Notes due 2028 (the “ Existing Second Lien Notes ,” and, together with the Existing First Lien Notes, the “ Existing Notes ”).”

NEXSTAR MEDIA GROUP, INC. amended Credit Agreement Amendment with Bank of America, N.A. and the financial institutions from time to time party thereto valued at $150 million and $2,750 million (effective 2026-03-19).

“pursuant to NMI established (i) an incremental senior secured term A loan facility in an aggregate principal amount of $150 million (the “2026 Nexstar Term Loan A Facility”) and (ii) an incremental senior secured term B loan facility in an aggregate principal amount of $2,750 million (the “2026 Nexstar Term Loan B Facility”).”

NEXSTAR MEDIA GROUP, INC. entered into Bridge Credit Agreement with Bank of America, N.A. and the financial institutions from time to time party thereto valued at up to $2,390 million (effective 2026-03-19).

“On the Closing Date, in connection with the consummation of the Merger, NMI entered into a credit agreement, dated as of March 19, 2026, by and among NMI, as the borrower, Bank of America, N.A. (“BofA”), as the administrative agent and the collateral agent, and the financial institutions from time to time party thereto (the “Bridge Credit Agreement”), pursuant to which NMI established a senior first lien secured increasing rate bridge facility in an aggregate principal amount of up to $2,390 million (the “Bridge Facility”).”

Prestige Consumer Healthcare Inc. entered into Asset Purchase Agreement with Foundation Consumer Brands, LLC valued at $1.045 billion in cash (effective 2026-03-19).

“On March 19, 2026, Prestige Brands, Inc. (“Purchaser”), a Delaware corporation and a wholly-owned subsidiary of Prestige Consumer Healthcare Inc. (the “Company”), entered into a definitive agreement (the “Asset Purchase Agreement”) with Foundation Consumer Brands, LLC (“Foundation”), a Delaware limited liability company. The Asset Purchase Agreement provides that, upon the terms and subject to the conditions set forth therein, Purchaser will acquire certain assets and assume certain liabilities primarily related to a portfolio of over-the-counter consumer health products, including Breathe Right® and certain other brands, for $1.045 billion in cash”

FEMASYS INC amended Omnibus Amendment and Consent Agreement with Consenting Holders (effective 2026-03-19).

“On March 19, 2026, the Company entered into an Omnibus Amendment and Consent Agreement (the “Amendment Agreement”) with the holders listed on Schedule I thereto (each, a “Consenting Holder” and collectively, the “Consenting Holders”).”

22nd Century Group, Inc. entered into Securities Purchase Agreement with certain investors valued at up to $20 million (effective 2026-03-20).

“On March 20, 2026, 22nd Century Group, Inc. (the “Company”) and certain investors (the “Investors”) entered into a securities purchase agreement (the “Securities Purchase Agreement”) with respect to the offer and sale of up to $20 million of shares of Series B Convertible Preferred Stock, stated value $1,000 per share (the “Series B Preferred Stock”) and warrants (the “Warrants”) to purchase shares of common stock (“Common Stock”) pursuant to a registered direct offering (collectively, the “Offering”).”

CapsoVision, Inc entered into Registration Rights Agreement with the Investors (effective 2026-03-16).

“In connection with the Private Placement, the Company entered into a registration rights agreement, dated March 16, 2026 (the “Registration Rights Agreement”), with the Investors, pursuant to which, among other things, the Company will (i) prepare and file with the Securities and Exchange Commission (the “SEC”) a registration statement to register for resale the Shares within 90 days after the closing of the Private Placement, and (ii) use commercially reasonable efforts to have such registration statement declared effective as soon as reasonably practicable following the filing thereof with the SEC.”

CapsoVision, Inc entered into Securities Purchase Agreement with selected accredited investors (the "Investors") valued at approximately $14 million (effective 2026-03-16).

“On March 16, 2026, CapsoVision, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with selected accredited investors (the “Investors”), for the purposes of raising approximately $14 million in aggregate gross proceeds for the Company (the “Private Placement”).”